Lupin signs Mary Kom for Shakti its Women's Cardiovascular Health Awareness Initiative MD Bureau9 March 2022 11:32 AM ISTThe campaign is aimed at increasing the awareness on heart diseases among women. Coronary heart diseases are the leading cause of death for women in...
Lupin gets CDSCO panel okay to manufacture, market tuberculosis drug Rifapentine Dr. Divya Colin5 March 2022 5:35 PM ISTNew Delhi: Drug major, Lupin has got a go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization to (CDSCO)...
Lupin's Efinaconazole Topical Solution gets USFDA nod MD Bureau4 March 2022 12:09 PM ISTLupin today announced that it has received approval from the USFDA for its ANDA, Efinaconazole Topical Solution, 10%to market a generic equivalent of...
Lupin gets USFDA nod for Sevelamer Hydrochloride Tablets MD Bureau3 March 2022 2:05 PM ISTSevelamer Hydrochloride Tablets, 800 mg is a generic equivalent of Renagel® Tablets, 800 mg of Genzyme Corporation.
Lupin appoints Dr Fabrice Egros as President, Corporate Development, Growth Markets MD Bureau24 Feb 2022 11:30 AM ISTMumbai : Global pharma major, Lupin Limited, has announced changes to its executive team with Dr. Fabrice Egros assuming responsibilities for Global...
Lupin Solosec gets USFDA nod to treat trichomoniasis, bacterial vaginosis in adolscents Ruchika Sharma18 Feb 2022 11:55 AM ISTSOLOSEC is the single-dose therapy for oral use.
Lupin, Medis ink pact for Orphan Drug NaMuscla Ruchika Sharma10 Feb 2022 12:16 PM ISTNaMuscla reduces myotonia symptoms in the people with NDM, resulting in a significant improvement in quality of life and other functional and...
Lupin bags USFDA nod for generic equivalent of Brovana Inhalation Solution Ruchika Sharma9 Feb 2022 11:52 AM ISTMumbai: Global pharma major Lupin Limited has recently announced that the company has received approval from the United States Food and Drug...
Lupin net profit up 24 percent at Rs 545 crore in Q3 Ruchika Sharma7 Feb 2022 10:00 AM ISTNew Delhi: Drugmaker Lupin on Friday reported a 24.45 per cent rise in its consolidated net profit at Rs 545.5 crore for the third quarter ended...
Lupin, Axantia collaborate for Pegfilgrastim Ruchika Sharma2 Feb 2022 11:09 AM ISTMumbai: Global pharma major, Lupin Limited, has recently announced that they have entered into a License, Supply and Technology Sharing agreement with...
Lupin, Exeltis ink agreement for Bacterial Vaginosis, Trichomoniasis drug SOLOSEC Ruchika Sharma28 Jan 2022 12:09 PM ISTSolosec is a single-dose therapy for oral use.
Lupin enters into partnership with Foncoo for China Ruchika Sharma19 Jan 2022 11:22 AM ISTMumbai: Global pharma major, Lupin Limited today announced that the company has entered into a partnership with Shenzhen Foncoo Pharmaceutical Co....
